GO
Loading...

Celgene Corp

More

  • Midday Glance: Biotechnology companies Tuesday, 20 Jan 2015 | 1:33 PM ET

    Amgen Inc. fell $2.21 or 1.4 percent, to $156.22. Biogen Idec rose $3.65 or 1.0 percent, to $356.40. Celgene Corp. fell$. 30 or. 2 percent, to $121.51.

  • Early Glance: Biotechnology companies Tuesday, 20 Jan 2015 | 10:33 AM ET

    Amgen Inc. fell $2.17 or 1.4 percent, to $156.26. Biogen Idec fell $1.29 or. 4 percent, to $351.46. Celgene Corp. fell$. 73 or. 6 percent, to $121.08.

  • TRENTON, N.J.— Celgene's new immune disorder drug, Otezla, has been approved in Europe for treating both psoriasis and a related type of arthritis, the company said Friday. Otezla, known chemically as apremilast, is the first new pill approved for psoriasis patients in 20 years and for patients with psoriatic arthritis in the last 15 years, according to Celgene...

  • Midday Glance: Biotechnology companies Friday, 16 Jan 2015 | 1:18 PM ET

    Amgen Inc. rose $4.31 or 2.8 percent, to $156.23. Biogen Idec rose $6.94 or 2.0 percent, to $346.82. Celgene Corp. rose $2.15 or 1.8 percent, to $120.42.

  • Early Glance: Biotechnology companies Friday, 16 Jan 2015 | 10:13 AM ET

    Amgen Inc. rose $1.19 or. 8 percent, to $153.11. Biogen Idec rose $2.82 or. 8 percent, to $342.70. Celgene Corp. rose $1.77 or 1.5 percent, to $120.04.

  • Final Glance: Biotechnology companies Thursday, 15 Jan 2015 | 6:08 PM ET

    Amgen Inc. fell $3.24 or 2.1 percent, to $151.92. Biogen Idec fell $8.87 or 2.5 percent, to $339.88. Celgene Corp. fell $2.83 or 2.3 percent, to $118.27.

  • Midday Glance: Biotechnology companies Thursday, 15 Jan 2015 | 1:59 PM ET

    Amgen Inc. fell $2.75 or 1.8 percent, to $152.41. Biogen Idec fell $4.64 or 1.3 percent, to $344.11. Celgene Corp. fell $3.28 or 2.7 percent, to $117.82.

  • Early Glance: Biotechnology companies Thursday, 15 Jan 2015 | 11:00 AM ET

    Amgen Inc. fell $1.45 or. 9 percent, to $153.71. Biogen Idec fell $4.30 or 1.2 percent, to $344.45. Celgene Corp. fell $1.82 or 1.5 percent, to $119.28.

  • Cramer's bankable Bobs: CEOs leading the way Tuesday, 13 Jan 2015 | 6:29 PM ET
    Bob Iger, chairman and CEO of the Walt Disney Company

    In a volatile environment, Jim Cramer nominates two bankable CEOs who will lead the way. And yes, they are both named Bob.

  • Cramer's bankable CEOs: Disney & Celgene  Tuesday, 13 Jan 2015 | 6:25 PM ET

    Mad Money host Jim Cramer congratulates Disney's CEO Bob Iger and Celgene's CEO Bob Hugin for taking their stocks to all-time highs in Tuesday's market.

  • 11 ways to play biotech Monday, 12 Jan 2015 | 6:59 PM ET

    Traders on CNBC's "Fast Money" outlined their strongest plays in the ever-volatile biotechnology space.

  • Midday movers: SanDisk, Chevron, Google & more Monday, 12 Jan 2015 | 12:42 PM ET

    Some of Monday's midday movers:

  • Celgene CEO: Creating a great future  Monday, 12 Jan 2015 | 11:45 AM ET

    CNBC's Meg Tirrell speaks to Robert Hugin, Celgene chairman & CEO, about the company's ambitious long-term guidance and broad-based drug pipeline.

  • Cramer's 10 lessons learned from 2014 Monday, 5 Jan 2015 | 6:10 PM ET
    Traders on the floor of the New York Stock Exchange.

    On a down day in the market, Jim Cramer thinks this is the perfect time to review the silly preconceptions of 2014.

  • NEW YORK, Dec 26- U.S. stocks rose on Friday, with major indexes hitting records and on track for a second straight weekly advance, though trading was light with many traders still out for the Christmas holiday. The advance continued Wall Street's recent upward bias, with the S&P up about 6 percent from a recent closing low hit earlier this month.

  • NEW YORK, Dec 26- U.S. stocks rose on Friday, with major indexes hitting new records and on track for a second straight weekly advance, though trading was light with many traders still out for the Christmas holiday. The advance continued Wall Street's recent upward bias, with the S&P up about 6 percent from a recent closing low hit earlier this month.

  • *Initial jobless claims fall for fourth straight week. *Biotech shares rebound after sharp two-day decline; energy falls. NEW YORK, Dec 24- U.S. stocks closed flat in a short session on Wednesday as investors found few reasons to push major indexes to their sixth straight day of gains despite strength in biotechs and bullish labor market data.

  • *Initial jobless claims fall for fourth straight week. *Equity markets close at 1 p.m. in holiday-shortened session. NEW YORK, Dec 24- U.S. stocks edged higher on Wednesday, with the Dow and S&P 500 at records and on track for a sixth straight daily advance as biotech stocks rallied and data pointed to improving economic conditions.

  • *Dow, S&P rise for 5th day, both end at records. NEW YORK, Dec 23- U.S. stocks rose on Tuesday, with the Dow closing above 18,000 for the first time ever and the S&P 500 ending at a record after an unexpectedly strong report on economic growth. The Dow rose as high as 18,069.22 and is up about 175 percent from a 12- year closing low hit on March 9, 2009.

  • NEW YORK, Dec 23- U.S. stocks rose for a fifth straight session on Tuesday, with the Dow climbing above 18,000 for the first time ever after an unexpectedly strong report on economic growth. Both the Dow and S&P 500 hit intraday records, and the S&P is on track for its 51st record close of 2014. The gains pushed the Dow as high as 18,051.14, and the blue-chip index is now up...